Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pittrow

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods]Wilhelm Kirch, Ralf Gold, Manfred Hensel, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 22, 2017
[Pilot study of psychiatric and social aspects of children and adolescents with fragile X syndrome]Frank Häßler, Franziska Gaese, Michael Colla, et al.
Journal of Clinical Immunology|September 15, 2012
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registryMartin Stangel, Ulrich Baumann, Michael Borte, et al.
BMC Psychiatry|December 21, 2013
EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X SyndromeFrank Haessler, Franziska Gaese, Michael Colla, et al.
Psychiatrische Praxis|February 3, 2015
[Psychiatric and Social Aspects of Patients with Fragile X Syndrome]David Pittrow, Franziska Gaese, Michael Colla, et al.
Therapeutic Advances in Neurological Disorders|May 3, 2016
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registryMartin Stangel, Ralf Gold, David Pittrow, et al.
American Journal of Hypertension|October 16, 2004
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlledPeter Bramlage, David Pittrow, Hans-Ulrich Wittchen, et al.
European Journal of Haematology|May 4, 2017
Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS studyMarcel Reiser, Michael Borte, Dörte Huscher, et al.
Atherosclerosis|December 21, 2010
Prognostic value of a low post-exercise ankle brachial index as assessed by primary care physiciansCurt Diehm, Harald Darius, David Pittrow, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 31, 2024
Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT studyThomas Noppeney, Eberhard Rabe, Ulrich Hoffmann, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Medizinische Klinik (Munich, Germany : 1983)|September 30, 2010
[Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods]Wilhelm Kirch, Ralf Gold, Manfred Hensel, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 22, 2017
[Pilot study of psychiatric and social aspects of children and adolescents with fragile X syndrome]Frank Häßler, Franziska Gaese, Michael Colla, et al.
Journal of Clinical Immunology|September 15, 2012
Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registryMartin Stangel, Ulrich Baumann, Michael Borte, et al.
BMC Psychiatry|December 21, 2013
EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X SyndromeFrank Haessler, Franziska Gaese, Michael Colla, et al.
Psychiatrische Praxis|February 3, 2015
[Psychiatric and Social Aspects of Patients with Fragile X Syndrome]David Pittrow, Franziska Gaese, Michael Colla, et al.
Therapeutic Advances in Neurological Disorders|May 3, 2016
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registryMartin Stangel, Ralf Gold, David Pittrow, et al.
American Journal of Hypertension|October 16, 2004
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlledPeter Bramlage, David Pittrow, Hans-Ulrich Wittchen, et al.
European Journal of Haematology|May 4, 2017
Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS studyMarcel Reiser, Michael Borte, Dörte Huscher, et al.
Atherosclerosis|December 21, 2010
Prognostic value of a low post-exercise ankle brachial index as assessed by primary care physiciansCurt Diehm, Harald Darius, David Pittrow, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 31, 2024
Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT studyThomas Noppeney, Eberhard Rabe, Ulrich Hoffmann, et al.
Pageof 15